VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

23 hedge funds and large institutions have $3.23M invested in VistaGen Therapeutics in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$1.88M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$187K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$99K
4
RC
4
RBF Capital
California
$35K
5
DADC
5
D.A. Davidson & Co
Montana
$105K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
CA
2
Corrado Advisors
New Jersey
$62K
3
BC
3
Bartlett & Co
Ohio
$0
4
BCWM
4
Bartlett & Co Wealth Management
Ohio
$0
5
UBS Group
5
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
– – – –
CIBC Private Wealth Group
27
CIBC Private Wealth Group
Georgia
$0 7 – –
PCP
28
Proficio Capital Partners
Massachusetts
$0 3 – –
1
2